Pollution levels as fine particulate matter in the air and how long they persistent was compared with marijuana joint, the bong with its bowl, the glass pipe, electronic vaping pen, and a Marlboro cigarette inn 60 controlled experiments. Cannabis joints were the most polluting – 3.5 times that of a Marlboro. The emission rate for
The rise of Autism Spectrum Disorder (ASD) is associated with increased cannabis exposure in a large US case controlled study that reflect a causation. https://www.longdom.org/open-access/epidemiological-associations-of-various-substances-and-multiple-cannabinoids-with-autism-in-usa.pdf
Parental cannabis use has been associated with adverse neurodevelopmental outcomes in offspring, but how such phenotypes are transmitted is largely unknown. Using reduced representation bisulphite sequencing (RRBS), we recently demonstrated that cannabis use is associated with widespread DNA methylation changes in human and rat sperm. Discs-Large Associated Protein 2 (DLGAP2), involved in synapse organization, neuronal
Cannabis cannot be safely recommended for the treatment of Autism or ADHD according to Harvard physicians.
Ocampo TL and Rans TS. Cannabis sativa: the unconventional “weed” allergen. Ann Allergy Asthma Immunol. 2015;114(3):187-192. doi: 10.1016/j.anai.2015.01.004
Young people (up to age 25) who use marijuana are 4-7 times more likely than adults to develop a drug problem.
9% of those who experiment with marijuana will become addicted. 17% of teenagers who experiment with marijuana become addicted. 25-50% of daily users become addicted.
Most Recent News
Increased marijuana poisoning in children follows increased availability and increased potency.
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
A strong placebo response may be largely responsible for the significant pain reduction observed in clinical trials of cannabis-based therapies, results of a new meta-analysis suggest. Investigators found that while the effect size of cannabinoids on pain intensity was significant, the placebo effect was about the same. “The data from the present meta-analysis, including 1459
Since 2005, diagnoses of cannabis use disorder have increased substantially among VHA patients, as they have in the general population and other patient populations. Possible explanations warranting investigation include decreasing perception of risk, changing laws, increasing cannabis potency, stressors related to growing socioeconomic inequality, and use of cannabis to self-treat pain. Clinicians and the public